HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines

Eur J Immunol. 2000 Jan;30(1):19-28. doi: 10.1002/1521-4141(200001)30:1<19::AID-IMMU19>3.0.CO;2-9.

Abstract

Human macrophage and T cell lines were stably transfected with HIV-1 wild-type Tat or Tat mutants in the cysteine-rich region displaying trans-dominant negative effects on HIV-1 life cycle. The expression of HLA class I and class II molecules was not affected by wild-type Tat. Tat mutants, instead, profoundly down-regulated in a dose-dependent fashion the expression of class II, but not of class I, in both cell types by acting at the transcriptional level. Down-regulation was manifested on constitutive and IFN-gamma-induced class II gene expression and did not correlate with reduced transcription of the AIR-1 gene product CIITA, the major transcriptional activator of class II genes, indicating that Tat mutants did not act by inhibiting AIR-1 gene expression. Class II down-modulation had important functional implications in macrophages, as both antigen processing and presenting capacity were inhibited. These results represent the first evidence that a modified HIV-1 Tat product can act as a potent immunosuppressor by inhibiting the HLA class II expression necessary for triggering both cellular and humoral responses against pathogens. The use of these HIV-1 Tat mutants also discloses new opportunities to investigate the molecular mechanisms underlying the coordinate HLA class II gene transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen Presentation
  • Cell Line
  • Cysteine
  • Down-Regulation
  • Gene Expression Regulation
  • Gene Products, tat / physiology*
  • HIV-1 / physiology*
  • Histocompatibility Antigens Class I / biosynthesis
  • Histocompatibility Antigens Class II / biosynthesis*
  • Histocompatibility Antigens Class II / genetics
  • Humans
  • Interferon-gamma / pharmacology
  • Macrophages / metabolism*
  • Nuclear Proteins*
  • RNA, Messenger / analysis
  • Structure-Activity Relationship
  • T-Lymphocytes / metabolism*
  • Trans-Activators / genetics
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, tat
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • MHC class II transactivator protein
  • Nuclear Proteins
  • RNA, Messenger
  • Trans-Activators
  • tat Gene Products, Human Immunodeficiency Virus
  • Interferon-gamma
  • Cysteine